After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of Biolife Solutions Inc is $1.21B. A total of 1.1 million shares were traded on the day, compared to an average of 360.46K shares.
In the most recent transaction, Mathew Aby J. sold 631 shares of BLFS for 25.13 per share on Dec 09 ’25. After the transaction, the EVP & Chief Scientific Officer now owns 349,755 company shares. In a previous transaction on Dec 09 ’25, Wichterman Troy sold 1,033 shares at 25.13 per share. BLFS shares that Chief Financial Officer owns now total 151,736.
Among the insiders who sold shares, Aebersold Sarah disposed of 713 shares on Dec 15 ’25 at a per-share price of $24.46. This resulted in the Chief Human Resources Officer holding 76,006 shares of BLFS after the transaction. In another insider transaction, Aebersold Sarah sold 233 shares at $25.13 per share on Dec 09 ’25. Company shares held by the Chief Human Resources Officer now total 76,719.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BLFS has a high of $29.62 and a low of $19.10.
As of this writing, BLFS has an earnings estimate of $0.0 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.01 per share and a lower estimate of $0.0. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BLFS’s latest balance sheet shows that the firm has $69.86M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $42.70M in liabilities at the time. Its Book Value Per Share was $7.37, while its Total Shareholder’s Equity was $478.05M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 4.80.
